224 related articles for article (PubMed ID: 25165992)
1. Interventions for treating acute bleeding episodes in people with acquired hemophilia A.
Zeng Y; Zhou R; Duan X; Long D; Yang S
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010761. PubMed ID: 25165992
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
Zeng Y; Zhou R; Duan X; Long D
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011907. PubMed ID: 27387850
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
Remmington T; Smith S
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011907. PubMed ID: 34423414
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
6. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010810. PubMed ID: 28685500
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
Iorio A; Matino D; D'Amico R; Makris M
Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010810. PubMed ID: 32761818
[TBL] [Abstract][Full Text] [Related]
10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
[TBL] [Abstract][Full Text] [Related]
11. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
[TBL] [Abstract][Full Text] [Related]
12. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
[TBL] [Abstract][Full Text] [Related]
13. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
[TBL] [Abstract][Full Text] [Related]
14. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors.
Hind D; Lloyd-Jones M; Makris M; Paisley S
Cochrane Database Syst Rev; 2004; (2):CD004449. PubMed ID: 15106253
[TBL] [Abstract][Full Text] [Related]
16. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.
Baudo F; Collins P; Huth-Kühne A; Lévesque H; Marco P; Nemes L; Pellegrini F; Tengborn L; Knoebl P;
Blood; 2012 Jul; 120(1):39-46. PubMed ID: 22618709
[TBL] [Abstract][Full Text] [Related]
17. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
Holme PA; Brosstad F; Tjønnfjord GE
Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
19. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study.
Holstein K; Liu X; Smith A; Knöbl P; Klamroth R; Geisen U; Eichler H; Miesbach W; Tiede A
Blood; 2020 Jul; 136(3):279-287. PubMed ID: 32268359
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for haemophilia.
Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010822. PubMed ID: 32342499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
